In a new strategic partnership with Salus Optima, IFF are developing a data driven personalized nutrition, health and wellness platform targeting metabolic health
Posted:
1 in 4 adults worldwide are affected by metabolic health issues such as obesity, pre-diabetes, high cholesterol, and pre-hypertension. IFF announced its plans for accelerated entry into the personalized nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalized nutrition, health and wellness company. Read more here.
NIHR annual report for 2024/25 has been published today, showcasing the impact of NIHR funded and supported research.
Hear from CEO @Lucy Chappell and find out about some of the ways NIHR research is:
changing lives
improving quality of…
A new wearable wristband could transform diabetes management by continuously tracking not just glucose, but also chemical and cardiovascular signals that affect disease progression and overall health. The technology was recently reported in Nature Biomedical Engineering.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us